Cyclin D1 overexpression perturbs DNA replication and induces replication-associated DNA double-strand breaks in acquired radioresistant cells

Cell Cycle

Volumn 12, Issue 5, 2013, Pages 773-782

  Shimura, Tsutomu ^a   Ochiai, Yasushi ^b   Noma, Naoto ^b   Oikawa, Toshiyuki ^b   Sano, Yui ^b   Fukumoto, Manabu ^b  

^a NATIONAL INSTITUTE OF PUBLIC HEALTH   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

Author keywords

Cyclin D1; DSBs; Mus81; Perturbation of DNA replication; Radioresistance

Indexed keywords

ATM PROTEIN; CYCLIN D; ENDONUCLEASE; MUTANT PROTEIN; PROTEIN KINASE; PROTEIN KINASE B;

APOPTOSIS; ARTICLE; CELL CYCLE S PHASE; CELL STRAIN HEPG2; CONTROLLED STUDY; DNA REPLICATION; DOUBLE STRANDED DNA BREAK; GENE OVEREXPRESSION; GENE SILENCING; HELA CELL; HUMAN; HUMAN CELL; RADIATION EXPOSURE; RADIOSENSITIVITY; TUMOR CELL;

EID: 84874603109     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.23719     Document Type: Article

References (40)

1. Hartwell LH, Weinert TA. Checkpoints: controls that ensure the order of cell cycle events. Science 1989; 246:629-34; PMID:2683079; http://dx.doi. org/10.1126/science.2683079
2. Szumiel I. Ionizing radiation-induced cell death. Int J Radiat Biol 1994; 66:329-41; PMID:7930835; http://dx.doi.org/10.1080/09553009414551271
3. Agami R, Bernards R. Distinct initiation and maintenance mechanisms cooperate to induce G1 cell cycle arrest in response to DNA damage. Cell 2000; 102:55-66; PMID:10929713; http://dx.doi.org/10.1016/S0092-8674(00)00010-6
4. Shimura T, Kakuda S, Ochiai Y, Nakagawa H, Kuwahara Y, Takai Y, et al. Acquired radioresistance of human tumor cells by DNA-PK/AKT/GSK3betamediated cyclin D1 overexpression. Oncogene 2010; 29:4826-37; PMID:20562919; http://dx.doi. org/10.1038/onc.2010.238
5. Sherr CJ, McCormick F. The RB and p53 pathways in cancer. Cancer Cell 2002; 2:103-12; PMID:12204530; http://dx.doi.org/10.1016/S1535-6108(02)00102-2
6. Giacinti C, Giordano A. RB and cell cycle progression. Oncogene 2006; 25:5220-7; PMID:16936740; http://dx.doi.org/10.1038/sj.onc.1209615
7. Kolupaeva V, Basilico C. Overexpression of cyclin E/CDK2 complexes overcomes FGF-induced cell cycle arrest in the presence of hypophosphorylated Rb proteins. Cell Cycle 2012; 11:2557-66; PMID:22713240; http://dx.doi.org/10. 4161/cc.20944
8. Kolupaeva V, Laplantine E, Basilico C. PP2A-mediated dephosphorylation of p107 plays a critical role in chondrocyte cell cycle arrest by FGF. PLoS ONE 2008; 3:e3447; PMID:18927618; http://dx.doi.org/10.1371/journal.pone.0003447
9. Hanse EA, Mashek DG, Becker JR, Solmonson AD, Mullany LK, Mashek MT, et al. Cyclin D1 inhibits hepatic lipogenesis via repression of carbohydrate response element binding protein and hepatocyte nuclear factor 4α. Cell Cycle 2012; 11:2681-90; PMID:22751438; http://dx.doi.org/10.4161/cc.21019
10. Sladek FM. The yin and yang of proliferation and differentiation: cyclin D1 inhibits differentiation factors ChREBP and HNF4α. Cell Cycle 2012; 11:3156-7; PMID:22895168; http://dx.doi.org/10.4161/cc.21721
11. Bartkova J, Lukas J, Strauss M, Bartek J. The PRAD-1/cyclin D1 oncogene product accumulates aberrantly in a subset of colorectal carcinomas. Int J Cancer 1994; 58:568-73; PMID:8056453; http://dx.doi.org/10.1002/ijc.2910580420
12. Bartkova J, Lukas J, Müller H, Lützhøft D, Strauss M, Bartek J. Cyclin D1 protein expression and function in human breast cancer. Int J Cancer 1994; 57:353-61; PMID:8168995; http://dx.doi.org/10.1002/ijc.2910570311
13. Bani-Hani K, Martin IG, Hardie LJ, Mapstone N, Briggs JA, Forman D, et al. Prospective study of cyclin D1 overexpression in Barrett's esophagus: association with increased risk of adenocarcinoma. J Natl Cancer Inst 2000; 92:1316-21; PMID:10944553; http://dx.doi.org/10.1093/jnci/92.16.1316
14. Casimiro MC, Pestell RG. Cyclin d1 induces chromosomal instability. Oncotarget 2012; 3:224-5; PMID:22538871
15. Leontieva OV, Lenzo F, Demidenko ZN, Blagosklonny MV. Hyper-mitogenic drive coexists with mitotic incompetence in senescent cells. Cell Cycle 2012; 11:4642-9; PMID:23187803; http://dx.doi. org/10.4161/cc.22937
16. Hitomi M, Stacey DW. Cyclin D1 production in cycling cells depends on ras in a cell-cycle-specific manner. Curr Biol 1999; 9:1075-84; PMID:10531005; http://dx.doi.org/10.1016/S0960-9822(99)80476-X
17. Filmus J, Robles AI, Shi W, Wong MJ, Colombo LL, Conti CJ. Induction of cyclin D1 overexpression by activated ras. Oncogene 1994; 9:3627-33; PMID:7970723
18. Vivanco I, Sawyers CL. The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev Cancer 2002; 2:489-501; PMID:12094235; http://dx.doi.org/10.1038/nrc839
19. Manning BD, Cantley LC. AKT/PKB signaling: navigating downstream. Cell 2007; 129:1261-74; PMID:17604717; http://dx.doi.org/10.1016/j. cell.2007.06.009
20. Shimura T. Acquired radioresistance of cancer and the AKT/GSK3β/cyclin D1 overexpression cycle. J Radiat Res 2011; 52:539-44; PMID:21881296; http://dx.doi. org/10.1269/jrr.11098
21. Bartkova J, Rezaei N, Liontos M, Karakaidos P, Kletsas D, Issaeva N, et al. Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 2006; 444:633-7; PMID:17136093; http://dx.doi.org/10.1038/nature05268
22. Di Micco R, Fumagalli M, Cicalese A, Piccinin S, Gasparini P, Luise C, et al. Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature 2006; 444:638-42; PMID:17136094; http://dx.doi.org/10. 1038/nature05327
23. Murfuni I, Nicolai S, Baldari S, Crescenzi M, Bignami M, Franchitto A, et al. The WRN and MUS81 proteins limit cell death and genome instability following oncogene activation. Oncogene 2012; PMID:22410776
24. Aggarwal P, Lessie MD, Lin DI, Pontano L, Gladden AB, Nuskey B, et al. Nuclear accumulation of cyclin D1 during S phase inhibits Cul4-dependent Cdt1 proteolysis and triggers p53-dependent DNA rereplication. Genes Dev 2007; 21:2908-22; PMID:18006686; http://dx.doi.org/10.1101/gad.1586007
25. Tane S, Chibazakura T. Cyclin A overexpression induces chromosomal double-strand breaks in mammalian cells. Cell Cycle 2009; 8:3900-3; PMID:19901524; http://dx.doi.org/10.4161/cc.8.23.10071
26. Li Z, Jiao X, Wang C, Shirley LA, Elsaleh H, Dahl O, et al. Alternative cyclin D1 splice forms differentially regulate the DNA damage response. Cancer Res 2010; 70:8802-11; PMID:20940395; http://dx.doi. org/10.1158/0008-5472.CAN- 10-0312
27. Hanada K, Budzowska M, Davies SL, van Drunen E, Onizawa H, Beverloo HB, et al. The structurespecific endonuclease Mus81 contributes to replication restart by generating double-strand DNA breaks. Nat Struct Mol Biol 2007; 14:1096-104; PMID:17934473; http://dx.doi.org/10.1038/nsmb1313
28. Shimura T, Torres MJ, Martin MM, Rao VA, Pommier Y, Katsura M, et al. Bloom's syndrome helicase and Mus81 are required to induce transient double-strand DNA breaks in response to DNA replication stress. J Mol Biol 2008; 375:1152-64; PMID:18054789; http://dx.doi.org/10.1016/j.jmb.2007.11.006
29. Regairaz M, Zhang YW, Fu H, Agama KK, Tata N, Agrawal S, et al. Mus81-mediated DNA cleavage resolves replication forks stalled by topoisomerase I-DNA complexes. J Cell Biol 2011; 195:739-49; PMID:22123861; http://dx.doi.org/10.1083/jcb.201104003
30. Fukami-Kobayashi J, Mitsui Y. Cyclin D1 inhibits cell proliferation through binding to PCNA and cdk2. Exp Cell Res 1999; 246:338-47; PMID:9925749; http://dx.doi.org/10.1006/excr.1998.4306
31. Prosperi E, Scovassi AI, Stivala LA, Bianchi L. Proliferating cell nuclear antigen bound to DNA synthesis sites: phosphorylation and association with cyclin D1 and cyclin A. Exp Cell Res 1994; 215:257-62; PMID:7982468; http://dx.doi.org/10.1006/excr.1994.1341
32. Xiong Y, Zhang H, Beach D. D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA. Cell 1992; 71:505-14; PMID:1358458; http://dx.doi.org/10.1016/0092-8674(92)90518-H
33. Kim JJ, Tannock IF. Repopulation of cancer cells during therapy: an important cause of treatment failure. Nat Rev Cancer 2005; 5:516-25; PMID:15965493; http://dx.doi.org/10.1038/nrc1650
34. Nguyen GH, Murph MM, Chang JY. Cancer Stem Cell Radioresistance and Enrichment: Where Frontline Radiation Therapy May Fail in Lung and Esophageal Cancers. Cancers (Basel) 2011; 3:1232-52; PMID:21603589; http://dx.doi.org/10. 3390/cancers3011232
35. Bommi-Reddy A, Almeciga I, Sawyer J, Geisen C, Li W, Harlow E, et al. Kinase requirements in human cells: III. Altered kinase requirements in VHL-/-cancer cells detected in a pilot synthetic lethal screen. Proc Natl Acad Sci USA 2008; 105:16484-9; PMID:18948595; http://dx.doi.org/10.1073/pnas. 0806574105
36. Diehl JA, Zindy F, Sherr CJ. Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway. Genes Dev 1997; 11:957-72; PMID:9136925; http://dx.doi.org/10.1101/gad. 11.8.957 0
37. Shimura T, Martin MM, Torres MJ, Gu C, Pluth JM, DeBernardi MA, et al. DNA-PK is involved in repairing a transient surge of DNA breaks induced by deceleration of DNA replication. J Mol Biol 2007; 367:665-80; PMID:17280685; http://dx.doi.org/10.1016/j. jmb.2007.01.018
38. Shimura T, Toyoshima M, Adiga SK, Kunoh T, Nagai H, Shimizu N, et al. Suppression of replication fork progression in low-dose-specific p53-dependent S-phase DNA damage checkpoint. Oncogene 2006; 25:5921-32; PMID:16682953; http://dx.doi. org/10.1038/sj.onc.1209624
39. Tung EW, Winn LM. Valproic acid-induced DNA damage increases embryonic p27(KIP1) and caspase-3 expression: a mechanism for valproic-acid induced neural tube defects. Reprod Toxicol 2011; 32:255-60; PMID:21708246; http://dx.doi.org/10.1016/j.reprotox. 2011.05.020
40. Dimitrova DS, Gilbert DM. The spatial position and replication timing of chromosomal domains are both established in early G1 phase. Mol Cell 1999; 4:983-93; PMID:10635323; http://dx.doi.org/10.1016/S1097-2765(00)80227-0